FILE – A sign marks an entrance to a Moderna building in Cambridge, Mass., May 18, 2020.AP Photo/Bill Sikes, FileFDA panel backs first-of-its-kind flu vaccine using mRNA technology
The Food and Drug Administration is evaluating Moderna's new shot, dubbed mFlusiva, for older Americans ahead of the winter flu season.
by Lauran Neergaard, Matthew Perrone | The Associated Press · 5 NBCDFW